U.S. Perfusion System Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Perfusion Systems Market 

5.1. COVID-19 Landscape: Perfusion Systems Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Perfusion Systems Market, By Component

8.1. U.S. Perfusion Systems Market Revenue and Volume, by Component

8.1.1. Hardware

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Disposables/Consumables

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Services/Maintenance

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. U.S. Perfusion Systems Market, By System Type - Hardware Only

9.1. U.S. Perfusion Systems Market Revenue and Volume, by System Type - Hardware Only

9.1.1. Cardiopulmonary Perfusion (Heart–Lung Machines)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. ECMO Systems

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Ex-Vivo Organ Perfusion (EVOP)

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Cell Perfusion Systems (Biopharma)

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. U.S. Perfusion Systems Market, By Component Type - Hardware Only 

10.1. U.S. Perfusion Systems Market Revenue and Volume, by Component Type - Hardware Only

10.1.1. Perfusion Controllers & Control Units

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Pumps

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Tubing, Connectors, & Flow Paths

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Sensors & Monitoring Modules

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Perfusion Bioreactor Vessels

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Media Reservoirs & Waste Collection Units

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. U.S. Perfusion Systems Market, By End-use Industry

11.1. U.S. Perfusion Systems Market Revenue and Volume, by End-use Industry

11.1.1. Hospitals - Cardiac Surgery

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Hospitals - Critical Care / ECMO

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Transplant Centers / Organ Preservation

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Biotech / Biopharma Manufacturing

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. U.S. Perfusion Systems Market, By Automation Level

12.1. U.S. Perfusion Systems Market Revenue and Volume, by Automation Level

12.1.1. Manual Perfusion Systems

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Semi-Automated Perfusion Systems

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Fully Automated & Closed-Sysyem Perfusion Systems

12.1.3.1. Market Revenue and Volume Forecast

Chapter 13. U.S. Perfusion Systems Market, Regional Estimates and Trend Forecast

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Component

13.1.6.2. Market Revenue and Volume Forecast, by System Type - Hardware Only

13.1.6.3. Market Revenue and Volume Forecast, by Component Type - Hardware Only

13.1.6.4. Market Revenue and Volume Forecast, by End-use Industry

13.1.6.5. Market Revenue and Volume Forecast, by Automation Level 

Chapter 14. Company Profiles

14.1. Getinge

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Medtronic, plc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. LivaNova PLC

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Terumo Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Nipro Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Fresenius SE and Co. KGaA (XENIOS AG)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Repligen Corporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Spectrum Medical

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Merck KGaA

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Harvard Bioscience, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms